Bilayer Therapeutics

Cambridge, United States

Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.

Jan 2022

Seed

Biotechnology Health Care Life Science Therapeutics

Top Investors

Kendall Capital Partners Diamond Biofund Inc.

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bilayer Therapeutics

Who are Bilayer Therapeutics's investors?

Bilayer Therapeutics's investors include Kendall Capital Partners, Diamond Biofund Inc..

Where is Bilayer Therapeutics headquartered?

Bilayer Therapeutics is headquartered in Cambridge, United States.

What does Bilayer Therapeutics do?

Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.

What stage is Bilayer Therapeutics at?

Bilayer Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2022.

MLA

"Bilayer Therapeutics — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/bilayer-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). Bilayer Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/bilayer-therapeutics

Wikipedia (cite web)

{{cite web |title=Bilayer Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bilayer-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K